Docencia
Ledipasvir Plus Sofosbuvir in Treatment- Naïve or-experienced Patients With Hepatitis C Genotype 5 Infection: An Open-Label, Phase 2 study Abergel A, et al. Lancet Infectious Diseases, 2016 (15-03-2016)
Dr. Antonio Rivero. Jefe de sección de Enfermedades Infecciosas. Hospital Universitario Reina Sofía. Córdoba
Switching from TDF to TAF in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: A randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. ENSAYO GS-US-292-0109 (01-03-2016)
Dr. Federico Pulido. Unidad de Infección VIH. Hospital 12 de Octubre. Madrid
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estmated glomerular filtration rate: a prospective international cohort study (15-02-2016)
Dra. María Jesús Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection (01-02-2016)
Dr. Félix Gutierrez. Departamento de Medicina Clínica. Hospital General Universitario. Elche
Withdrawing inactive NRTIs in HIV-1 sujects with suppressed viraemia: a randomized trial (15-01-2016)
Dr. Josep Maria Llibre. Departamento de Medicina interna y Unidad de VIH. Hospital Germans Trias i Pujol. Badalona
Estudios ASTRAL 1, 2, 3 Y 4 (30-12-2015)
Dr. Juan Berenguer. Consultor de la Unidad de Enf. Infecciosas y VIH. Hospital Universitario Gregorio Marañón. Madrid
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in AfricaThe TEMPRANO ANRS 12136 Study GroupN Engl J Med. Volume 373(9):808-822. August 27, 2015 (15-12-2015)
Dr. Antonio Rivero Román. Jefe de sección de Enfermedades Infecciosas.Hospital Universitario Reina Sofía. Córdoba
High-Dose Vitamin D and Calcium Attenuates Bone Loss with Antiretroviral Therapy Initiation: A Prospective, Randomized Placebo-Controlled Trial for Bone Health in HIV-Infected Individuals (01-12-2015)
Dr. Federico Pulido. Unidad de Infección VIH Hospital 12 de Octubre. Madrid
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phaseof a pragmatic open-label randomised trial (15-11-2015)
Dra. María Jesus Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3,non-inferiority trials (01-11-2015)
Dr. Félix Gutierrez. Departamento de Medicina Clínicia Hospital General Universitario. Elche
